(Q44530572)

3 December 2017

The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone (English)

1 reference

3 December 2017

1 reference

2

1 reference

3 December 2017

1

Christian Otte

1 reference

3 December 2017

Alexander Yassouridis

3

1 reference

3 December 2017

Josef Arlt

4

1 reference

3 December 2017

Nina Stober

5

1 reference

3 December 2017

Philip Maass

6

1 reference

3 December 2017

Klaus Wiedemann

7

1 reference

3 December 2017

Michael Kellner

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

3 December 2017

1 reference

3 December 2017

73

1 reference

3 December 2017

1835-1845

1 reference

3 December 2017

14

1 reference

Physiological activity and receptor binding of 9 alpha fluorohydrocortisone.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Mineralocorticoid Receptor Blockade by Canrenoate Increases Both Spontaneous and Stimulated Adrenal Function in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Brain corticosteroid receptor balance in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Adrenocorticotropin inhibition by restoration of normal evening cortisol levels: a measure of putative hippocampus-mediated glucocorticoid feedback in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Mineralocorticoid receptor function in patients with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Nongenomic actions of steroid hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Effects of deoxycorticosterone acetate and diazepam on neuropeptidergic neurons in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Expression of 11beta-hydroxylase and aldosterone synthase genes in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotropin-releasing-hormone-stimulated adrenocorticotropic hormone and cortisol secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11 beta-hydroxysteroid dehydrogenase: a model for 11-HSD I deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

The brain mineralocorticoid receptor: greedy for ligand, mysterious in function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Short term cardiovascular effects of aldosterone in healthy male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Metyrapone inhibition of 3H-hydrocortisone uptake and binding in various brain regions of the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

11beta-hydroxysteroid dehydrogenase type I in the brain; thickening the glucocorticoid soup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

Mineralocorticoid receptor function in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900513-7

10.1016/S0024-3205(03)00513-7

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference